Title: ChipCytometry: high-plex proteomics in tissue samples
Date: Monday 23 March 2020
Duration: 1 hour
Immune cell profiling – both pre- and post-treatment – is a key part of characterizing the complexities of cancer biology to develop and commercialize new therapy options. ChipCytometry allows for the quantitative analysis of virtually unlimited protein biomarkers in a single sample. The technology combines high-resolution HDR imaging with AI-powered cell-segmentation software to deliver quantitative biomarker analysis with true single-cell resolution, enabling deep phenotyping of every individual cell in your sample. With over 40 validated markers for tissue samples and more than 110 validated markers for PBMCs, this technology has broad applications to clinical and pre-clinical studies in oncology, immunology and drug development.
What will you learn?
Who may this interest?